Description

Dactinoz (Dacarbazine Injection) is a prescription chemotherapy medicine containing Dacarbazine, an alkylating agent used to treat certain types of cancer. It works by damaging the DNA of rapidly dividing cancer cells, helping to slow or stop their growth. Dacarbazine is commonly used as part of combination chemotherapy regimens under the supervision of experienced oncology specialists. It is administered in hospitals or specialized cancer treatment centers. (medlineplus.gov) Dactinoz is given by intravenous (IV) infusion by qualified healthcare professionals. The dosage and treatment schedule are determined by the oncologist based on the patient's cancer type, body surface area, overall health, and treatment protocol. Key Benefits Contains Dacarbazine, a well-established anticancer medicine. Used in combination chemotherapy regimens for selected cancers. Administered under specialist oncology supervision. Sterile injectable formulation for hospital use. Indications Dactinoz (Dacarbazine Injection) may be prescribed for the treatment of: Metastatic malignant melanoma (advanced skin cancer) Hodgkin lymphoma, typically as part of combination regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine). (medlineplus.gov) Administration For intravenous (IV) use only. Must be administered by trained healthcare professionals in an oncology setting. Regular monitoring of blood counts, liver function, kidney function, and overall clinical condition is required during treatment due to the potential for serious side effects. Storage Store according to the manufacturer's recommendations. Protect from light where specified, and keep out of reach of children. Reconstitution and handling should be performed using appropriate cytotoxic safety precautions. Important: Dactinoz (Dacarbazine Injection) is a prescription-only chemotherapy medicine. It should only be used under the guidance of a qualified oncologist with appropriate monitoring for safety and treatment response.